HCN Oncology Essentials: Accelerated Biological Aging, Another Prostate Cancer Guideline Update, Tense Parent-Oncologist RelationshipsDecember 14, 2021 | Oncology Hematology/Oncology Controversy Prompts Another Update to the NCCN Guidelines for Prostate Cancer Bowing to criticism from doctors, the National Comprehensive Cancer Network (NCCN) has again updated its guidelines for prostate cancer. The previous update, released this past September, had changed the recommendation about active surveillance for low-risk prostate cancer to state that active surveillance was no longer the “preferred” management option for patients with low-risk prostate cancer and a life expectancy of 10 years or more. Many physicians criticized this change, saying it could lead to overtreatment of low-risk patients by implying that active surveillance, surgery, and radiation are equivalent management options. As a result, NCCN has further revised its guidelines to now state that active surveillance is preferred for most patients with low-risk prostate cancer and a life expectancy of 10 years or more. Read full article Hematology Parents Report Challenging Relationships With Pediatric Oncology Clinicians Having a child with cancer is one of the most stressful events for any parent to endure. And, according to a report in JAMA Network Open, that stress contributes to often fractious relationships between parents and the medical teams treating their cancer-stricken children. JAMA reports that a quarter of parents have a difficult, or challenging, relationship with their pediatric oncologist and related medical team. The study also found that the tense feelings are mutual between parents and doctors. Among physicians surveyed, 37.6% reported that they felt the relationships they had with parents of the children they treated were challenging. Read full article